Form 4: ICU Medical CFO Bonnell Exercises Equity Awards

ICU Medical's Chief Financial Officer, Brian Bonnell, reported the exercise and settlement of performance-based and restricted stock units, along with associated tax withholdings.

Summary

• Chief Financial Officer Brian Bonnell acquired 11,400 shares of Common Stock from the settlement of Performance-based Restricted Stock Units (PRSUs).
• These PRSUs were granted on March 15, 2023, and were earned at 117% of target following performance certification by the Compensation Committee on February 11, 2026.
• Bonnell also acquired 3,248 shares of Common Stock from the settlement of Restricted Stock Units (RSUs).
• A total of 5,800 shares were disposed of at $125.85 per share for tax withholding related to the PRSU settlement.
• An additional 1,795 shares were disposed of at $125.85 per share for tax withholding related to the RSU settlement.
• Following these transactions, Bonnell's direct beneficial ownership of Common Stock is 71,750 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, primarily due to the successful vesting of performance-based units at 117% of target, indicating strong internal performance. The dispositions are routine tax-related actions.

Positives

• CFO Brian Bonnell acquired a total of 14,648 shares of Common Stock through the settlement of equity awards.
• Performance-based Restricted Stock Units (PRSUs) were earned at 117% of target, indicating strong company performance against set metrics.

Negatives

• A total of 7,595 shares were disposed of to cover tax obligations, representing a reduction in direct share ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as the exercise of equity awards, are routine events for executives and often reflect compensation structures rather than direct market sentiment. The earning of PRSUs at 117% of target suggests the company met or exceeded internal performance goals, which can be a positive signal for operational execution within the medical device industry.

Stakeholder Impact

• Shareholders: The vesting of performance-based units at 117% of target could be seen as a positive indicator of management's performance and alignment with shareholder interests.
• Employees: Reflects standard executive compensation practices, potentially signaling a healthy compensation structure within the company.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, specifically the vesting and exercise of equity awards and subsequent tax-related share dispositions. While the 117% achievement of performance targets is positive, these transactions do not provide new fundamental information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as it reflects a neutral impact on the company's valuation based solely on this filing.

Keywords

ICU Medical, ICUI, Form 4, Insider Transaction, Equity Awards, CFO, Stock Units, Performance Shares, Restricted Stock Units